Skrzypecki Janusz, Grabska-Liberek Iwona, Przybek Joanna, Ufnal Marcin
a Department of Experimental Physiology and Pathophysiology, Laboratory of Centre for Preclinical Research , Medical University of Warsaw , Warsaw , Poland.
b Department of Ophthalmology , Medical Center for Postgraduate Education , Warsaw , Poland.
Curr Med Res Opin. 2018 Mar;34(3):521-529. doi: 10.1080/03007995.2017.1415203. Epub 2018 Jan 5.
It has been postulated that intraocular pressure, an important glaucoma risk factor, correlates positively with arterial blood pressure (blood pressure). However, results of experimental and clinical studies are often contradictory. It is hypothesized that, in some hypertensive patients, disturbances in intraocular pressure regulation may depend on biological effects of blood borne hormones underlying a particular type of hypertension, rather than on blood pressure level itself.
This review compares the effects of hormones on blood pressure and intraocular pressure, in order to identify a hormonal profile of hypertensive patients with an increased risk of intraocular pressure surge. The PUBMED database was searched to identify pre-clinical and clinical studies investigating the role of angiotensin II, vasopressin, adrenaline, noradrenaline, prostaglandins, and gaseous transmitters in the regulation of blood pressure and intraocular pressure.
Studies included in the review suggest that intraocular and blood pressures often follow a different pattern of response to the same hormone. For example, vasopressin increases blood pressure, but decreases intraocular pressure. In contrast, high level of nitric oxide decreases blood pressure, but increases intraocular pressure.
Arterial hypertension is associated with altered levels of blood borne hormones. Contradicting results of studies on the relationship between arterial hypertension and intraocular pressure might be partially explained by diverse effects of hormones on arterial and intraocular pressures. Further studies are needed to evaluate if hormonal profiling may help to identify glaucoma-prone patients.
眼压是青光眼的一个重要危险因素,据推测它与动脉血压(血压)呈正相关。然而,实验和临床研究的结果往往相互矛盾。据推测,在一些高血压患者中,眼压调节紊乱可能取决于特定类型高血压背后血源性激素的生物学效应,而非血压水平本身。
本综述比较了激素对血压和眼压的影响,以确定眼压激增风险增加的高血压患者的激素特征。检索了PUBMED数据库,以识别研究血管紧张素II、血管加压素、肾上腺素、去甲肾上腺素、前列腺素和气态递质在血压和眼压调节中作用的临床前和临床研究。
该综述纳入的研究表明,眼压和血压对同一激素的反应模式往往不同。例如,血管加压素会升高血压,但会降低眼压。相反,高水平的一氧化氮会降低血压,但会升高眼压。
动脉高血压与血源性激素水平改变有关。关于动脉高血压与眼压之间关系的研究结果相互矛盾,可能部分是由于激素对动脉压和眼压的不同作用所致。需要进一步研究以评估激素谱分析是否有助于识别易患青光眼的患者。